Literature DB >> 12917320

Characterization of the low molecular weight human serum proteome.

Radhakrishna S Tirumalai1, King C Chan, DaRue A Prieto, Haleem J Issaq, Thomas P Conrads, Timothy D Veenstra.   

Abstract

Serum potentially carries an archive of important histological information whose determination could serve to improve early disease detection. The analysis of serum, however, is analytically challenging due to the high dynamic concentration range of constituent protein/peptide species, necessitating extensive fractionation prior to mass spectrometric analyses. The low molecular weight (LMW) serum proteome is that protein/peptide fraction from which high molecular weight proteins, such as albumin, immunoglobulins, transferrin, and lipoproteins, have been removed. This LMW fraction is made up of several classes of physiologically important proteins such as cytokines, chemokines, peptide hormones, as well as proteolytic fragments of larger proteins. Centrifugal ultrafiltration of serum was used to remove the large constituent proteins resulting in the enrichment of the LMW proteins/peptides. Because albumin is known to bind and transport small molecules and peptides within the circulatory system, the centrifugal ultrafiltration was conducted under solvent conditions effecting the disruption of protein-protein interactions. The LMW serum proteome sample was digested with trypsin, fractionated by strong cation exchange chromatography, and analyzed by microcapillary reversed-phase liquid chromatography coupled on-line with electrospray ionization tandem mass spectrometry. Analysis of the tandem mass spectra resulted in the identification of over 340 human serum proteins; however, not a single peptide from serum albumin was observed. The large number of proteins identified demonstrates the efficacy of this method for the removal of large abundant proteins and the enrichment of the LMW serum proteome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917320     DOI: 10.1074/mcp.M300031-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  162 in total

1.  Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.

Authors:  Angela Y Wehr; Wei-Ting Hwang; Ian A Blair; Kenneth H Yu
Journal:  J Proteome Res       Date:  2012-02-15       Impact factor: 4.466

Review 2.  Comparative human salivary and plasma proteomes.

Authors:  J A Loo; W Yan; P Ramachandran; D T Wong
Journal:  J Dent Res       Date:  2010-08-25       Impact factor: 6.116

3.  Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.

Authors:  Claudia Fredolini; Francesco Meani; Alessandra Luchini; Weidong Zhou; Paul Russo; Mark Ross; Alexis Patanarut; Davide Tamburro; Guido Gambara; David Ornstein; Franco Odicino; Monica Ragnoli; Antonella Ravaggi; Francesco Novelli; Devis Collura; Leonardo D'Urso; Giovanni Muto; Claudio Belluco; Sergio Pecorelli; Lance Liotta; Emanuel F Petricoin
Journal:  AAPS J       Date:  2010-06-12       Impact factor: 4.009

4.  Maximizing early detection of esophageal squamous cell carcinoma via SILAC-proteomics.

Authors:  Kevin K Lee; Kristina Todorova; Anna Mandinova
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

Review 5.  Generating and navigating proteome maps using mass spectrometry.

Authors:  Christian H Ahrens; Erich Brunner; Ermir Qeli; Konrad Basler; Ruedi Aebersold
Journal:  Nat Rev Mol Cell Biol       Date:  2010-10-14       Impact factor: 94.444

6.  The extent and effects of peptide sequence scrambling via formation of macrocyclic B ions in model proteins.

Authors:  Irine S Saminathan; X Simon Wang; Yuzhu Guo; Olga Krakovska; Sébastien Voisin; Alan C Hopkinson; K W Michael Siu
Journal:  J Am Soc Mass Spectrom       Date:  2010-09-09       Impact factor: 3.109

7.  Precursor ion exclusion for enhanced identification of plasma biomarkers.

Authors:  Wells W Wu; Rong-Fong Shen; Sung-Soo Park; Bronwen Martin; Stuart Maudsley
Journal:  Proteomics Clin Appl       Date:  2012-06       Impact factor: 3.494

8.  Identification of glycoproteins from mouse skin tumors and plasma.

Authors:  Yuan Tian; Karen S Kelly-Spratt; Christopher J Kemp; Hui Zhang
Journal:  Clin Proteomics       Date:  2008-12-01       Impact factor: 3.988

9.  Comparison of nanotube-protein corona composition in cell culture media.

Authors:  Jonathan H Shannahan; Jared M Brown; Ran Chen; Pu Chun Ke; Xianyin Lai; Somenath Mitra; Frank A Witzmann
Journal:  Small       Date:  2013-01-16       Impact factor: 13.281

10.  Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach.

Authors:  Wei-Jun Qian; Matthew E Monroe; Tao Liu; Jon M Jacobs; Gordon A Anderson; Yufeng Shen; Ronald J Moore; David J Anderson; Rui Zhang; Steve E Calvano; Stephen F Lowry; Wenzhong Xiao; Lyle L Moldawer; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2005-03-07       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.